SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-032609
Filing Date
2024-03-08
Accepted
2024-03-08 21:30:20
Documents
2
Period of Report
2024-03-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm248303-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm248303-1_4seq1.xml 4 4176
2 EXHIBIT 24 tm248303d1_ex24.htm EX-24 5603
  Complete submission text file 0001104659-24-032609.txt   11379
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Issuer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1111 MAIN STREET SUITE 660 VANCOUVER WA 98660
Business Address
Lalezari Jacob P (Reporting) CIK: 0002001963 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-49908 | Film No.: 24736381